doi:10.1016/j.tvr.2022.200245 [26] Scalliet et al. 2017 CERN Yellow Rep Sch Proc . 1:1-1. doi:10.23730/CYRSP-2017-001.1 [27] Helm et al. 2023 Strahlenther Onkol . 199(12):1225-1241. doi:10.1007/s00066- [...] doi:10.3389/fonc.2022.878675 [29] Goodhead 1999 J Radiat Res (Tokyo) . 1999;40(Suppl):S1-S13. doi:10.1269/jrr.40.S1 To read more: Rühle et al., Autoimmunity. 50(2):133-140 (2017) Rödel et al., Front Immunol [...] therapy (XRT), when compared to untreated negative controls (NC). Addition of immunotherapy (Figure 1: a mix checkpoint inhibitors, CPI) fosters the immunogenic response, leading to further reduction of